Astrana Health, Inc.

NASDAQ:ASTH

Medical - Care Facilities

Healthcare
$29.65 +2.70%

+$1.03 today

Market cap
$1.47B
Beta
0.94
P/E (TTM)
63.3
EPS (TTM)
$0.62
52W Low $18.08High $40.13

Volume 0.52M

Average 0.51M

ASTH Interest Income

Income earned on cash, deposits, and investments held by the company.

Astrana Health, Inc.NASDAQ: ASTH

Interest Income · Q1 FY2026 · quarter ended Mar 2026

Interest income growth accelerates

Q1 FY2026 interest income of $3.82M rose 65.1% year over year, ahead of the +6.5% change in trailing-twelve-month interest income. Sequentially, it fell 4.3% from the prior quarter. Over 3 fiscal years it compounded at +83.2% a year.

Context

  • Interest income amounted to 0.4% of revenue in FY2025, down 0.3 pp from a year earlier.
  • Interest income increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +65.1% holds above the trailing-twelve-month pace of +6.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.82M-4.3% QoQ
Last fiscal yearDec 2025
$12.16M-16.2% YoY
LTMMar 2026
$13.66M+6.5% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+65.1%——
1 year-16.2%——
3-year CAGR+83.2%——
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
12.16M USD
Year-over-year change
-16.2%
4-year CAGR
+66.8%

Interest Income vs competitors

How ASTH compares with its peers on the latest reported figures

  • ASTH's LTM Mar 2026 interest income of $13.66M is the highest of the 4 companies compared; the peer median is $0.
  • Its year-over-year change of +6.5% is the highest of 2, against a peer median of -39.2%.
  • Interest income amounts to 0.4% of revenue for ASTH, versus a peer median of 0.0%.
ASTH Competitors Peer median
Interest Income for ASTH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ASTHAstrana Health, Inc.LTM Mar 2026$13.66M +6.5%+83.2%0.4%
PRVAPrivia Health Group, Inc.LTM Jun 2026$6.25M -39.2%+161.6%0.3%
AGLAgilon Health, Inc.LTM Mar 2026$0 ——0.0%
NUTXNutex Health, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding ASTH) $0-39.2%+161.6%0.0%

Competitors are the stored peer set for ASTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue773.92M1.14B1.39B2.03B3.18B
Cost of Revenue596.14M944.69M1.17B1.76B2.89B
Gross Profit177.77M199.48M214.96M271.39M295.78M
Gross Margin23.0%17.4%15.5%13.3%9.3%
Research & Development00000
Selling, General & Admin62.08M77.67M112.6M154.11M217.26M
Operating Expenses79.59M95.21M130.35M182.04M217.26M
Depreciation & Amortization17.52M17.54M17.75M27.93M45.75M
EBITDA100.66M112.08M123.69M141.84M135.28M
EBITDA Margin13.0%9.8%8.9%7.0%4.3%
Operating Income98.18M104.27M84.61M89.35M78.53M
Operating Margin12.7%9.1%6.1%4.4%2.5%
Interest Income1.57M1.98M14.21M14.51M12.16M
Interest Expense5.39M7.92M16.1M33.1M49.93M
Other Income / Expenses(20.43M)(17.65M)5.23M(8.53M)(38.92M)
Income Before Tax77.75M86.62M89.84M80.82M39.61M
Pre-Tax Margin10.0%7.6%6.5%4.0%1.2%
Income Tax Expense31.69M40.88M31.99M30.89M15.53M
Net Income68.92M45.17M60.72M43.15M22.49M
Net Margin8.9%3.9%4.4%2.1%0.7%
EPS (Basic)1.571.001.300.910.46
EPS (Diluted)1.520.991.290.900.46
Weighted Avg Shares43.83M44.97M46.71M47.69M49.08M
Weighted Avg Shares (Diluted)45.4M45.6M47.07M48.22M49.37M

Astrana Health, Inc.

NASDAQ:ASTH

Intrinsic Alpha fair value

Locked

Current Price

$29.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.